This article provides an update on HIND's SEC filings, specifically an 8-K filing related to corporate changes and voting matters. The filing was made on May 9, 2025, and includes exhibits EX-3.1 and EX-99.1.
Original sourceHINDNASDAQHealthcare
VYOME HOLDINGS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$1.58
-3.07%
Alpha Vantage · 11/6/2026
Industry: BiotechnologyCategory: Domestic Common StockCurrency: USDNews: 1 recent
Analyze HIND free One-year price history
Adjusted daily closes · 252 observations · as of Nov 6, 2026
1 month
-22.2%
3 months
-28.5%
6 months
-23.3%
1 year
-72.1%
Year to date
-54.1%
52-week range
$1.58 – $5.73
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$11.1M
P/E
-1
P/B
1.5
P/S
-5.6
Revenue
-$1.98M
Net income
-$10.75M
Diluted EPS
-72.1
Gross margin
52.30%
Net margin
544.10%
Return on equity
-198.70%
Total debt
$17.31K
Cash
$7.89M
Free cash flow
$524.47K
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $26.96K | -$685.56K | 43.20% | -2543.30% | -$903.71K |
| Mar 31, 2026 | $31.59K | -$962.91K | 52.70% | -3048.10% | -$1.44M |
| Dec 31, 2025 | -$2.07M | -$672.2K | 52.10% | 32.50% | -$1.48M |
| Sep 30, 2025 | $34.63K | -$8.43M | 52.10% | -24356.20% | $4.34M |
| Jun 30, 2025 | $1.24M | -$2.63M | 48.20% | -211.80% | -$4.49M |
| Mar 31, 2025 | $1.11M | $1.47M | 61.20% | 132.40% | -$2.12M |
| Dec 31, 2024 | $1.81M | -$1.76M | 73.10% | -97.60% | -$687K |
| Sep 30, 2024 | $2.29M | -$1.58M | 62.80% | -69.00% | -$311K |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent HIND news
All market newsYahoo Finance Australia·48 signal
HIND 8-K & SEC Filings